191 related articles for article (PubMed ID: 25076295)
21. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
22. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
[TBL] [Abstract][Full Text] [Related]
23. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J
Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
[TBL] [Abstract][Full Text] [Related]
24. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Kandalaft PL; Gown AM; Isacson C
Am J Clin Pathol; 2014 Dec; 142(6):830-6. PubMed ID: 25389337
[TBL] [Abstract][Full Text] [Related]
25. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT
Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of immunohistochemically detected surfactant--apoprotein-A in malignant tumors located in the lungs: report of two cases.
Goldmann T; Galle J; Wiedorn KH; Deutschbein ME; Neuhaus M; Branscheid D; Vollmer E
Ann Diagn Pathol; 2001 Apr; 5(2):84-90. PubMed ID: 11294993
[TBL] [Abstract][Full Text] [Related]
27. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Kim JH; Kim YS; Choi YD; Lee JS; Park CS
Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
[TBL] [Abstract][Full Text] [Related]
29. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
30. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK
Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690
[TBL] [Abstract][Full Text] [Related]
31. Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Mukhopadhyay S; Katzenstein AL
Am J Clin Pathol; 2012 Nov; 138(5):703-11. PubMed ID: 23086771
[TBL] [Abstract][Full Text] [Related]
32. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
33. Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Genova SN; Belovezhdov VT; Bichev SN; Danev VH
Folia Med (Plovdiv); 2017 Jun; 59(2):174-182. PubMed ID: 28704186
[TBL] [Abstract][Full Text] [Related]
34. Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Jain D; Mallick SR; Singh V; Singh G; Mathur SR; Sharma MC
Appl Immunohistochem Mol Morphol; 2016; 24(5):e34-40. PubMed ID: 26808134
[TBL] [Abstract][Full Text] [Related]
35. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
36. Fine-needle aspiration of cystic pancreatic mucinous tumor: oncotic cell as an aiding diagnostic feature in paucicellular specimens.
Xiao GQ
Diagn Cytopathol; 2009 Feb; 37(2):111-6. PubMed ID: 19021219
[TBL] [Abstract][Full Text] [Related]
37. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
El Hag M; Schmidt L; Roh M; Michael CW
Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
[TBL] [Abstract][Full Text] [Related]
38. Napsin A expression in lung and kidney neoplasia: a review and update.
Ordóñez NG
Adv Anat Pathol; 2012 Jan; 19(1):66-73. PubMed ID: 22156835
[TBL] [Abstract][Full Text] [Related]
39. Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Wu J; Zhang Y; Ding T; Cheng R; Gong W; Guo Y; Luo Y; Pan Y; Zhai Q; Sun W; Lin D; Sun B
Endocr Pathol; 2020 Mar; 31(1):39-45. PubMed ID: 31788765
[TBL] [Abstract][Full Text] [Related]
40. A word of caution regarding napsin A expression in squamous cell carcinomas of the lung.
Ordóñez NG
Am J Surg Pathol; 2012 Mar; 36(3):396-401. PubMed ID: 22198009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
